Clinical trial
Other Effects of Fluvastatin Are Investigated in Patients With Metabolic…
NCT00138528 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00138528 |
|---|---|
| Title | Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome |
| Official title | Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Fluvastatin |
| Enrollment | 55 |
| Start date | Oct 1, 2004 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Aug 30, 2005 |
| Last update posted | Feb 23, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: